InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
0.00%
)
US TECH 100
19,207.60
(
0.23%
)
Dow Jones
39,118.86
(
0.00%
)
Brent Oil
85.47
(
0.42%
)
Bitcoin
62,773.74
(
0.28%
)

Replies to post #841 on Oncternal Therapeutics Inc (ONCT)

Replies to #841 on Oncternal Therapeutics Inc (ONCT)

Chag

09/21/18 6:34 PM

#842 RE: Cherry #841

Not really. They clinical phase 2 report was not as expected. The stock had been climbing this year and even had a projected value of $45. Insiders had been purchasing since May at $14 or higher.